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Cardiac tissue engineering, which combines cells and supportive scaffolds, is an emerging treatment 
for restoring cardiac function after myocardial infarction (MI), although, the optimal construct remains 
a challenge. We developed two engineered cardiac grafts, based on decellularized scaffolds from 
myocardial and pericardial tissues and repopulated them with adipose tissue mesenchymal stem cells 
(ATMSCs). The structure, macromechanical and micromechanical scaffold properties were preserved 
upon the decellularization and recellularization processes, except for recellularized myocardium 
micromechanics that was ∼2-fold stiffer than native tissue and decellularized scaffolds. Proteome 
characterization of the two acellular matrices showed enrichment of matrisome proteins and major 
cardiac extracellular matrix components, considerably higher for the recellularized pericardium. 
Moreover, the pericardial scaffold demonstrated better cell penetrance and retention, as well as 
a bigger pore size. Both engineered cardiac grafts were further evaluated in pre-clinical MI swine 
models. Forty days after graft implantation, swine treated with the engineered cardiac grafts showed 
significant ventricular function recovery. Irrespective of the scaffold origin or cell recolonization, all 
scaffolds integrated with the underlying myocardium and showed signs of neovascularization and 
nerve sprouting. Collectively, engineered cardiac grafts -with pericardial or myocardial scaffolds- were 
effective in restoring cardiac function post-MI, and pericardial scaffolds showed better structural 
integrity and recolonization capability.
Cardiac tissue engineering, which combines the use of cells and biomaterials, has been proposed as an alternative 
therapy for myocardial infarction (MI)1, with the goals of repairing the damaged myocardium, recovering heart 
function, and preventing ventricular remodeling in end-stage heart failure. In tissue engineering, cells are embed-
ded within a natural or synthetic scaffold, avoiding the harsh infarcted milieu, and improving the low cell reten-
tion and survival reported for direct cell injection2,3. Accordingly, the scaffold biomaterial is crucial, and ideally 
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should closely resemble the physiological myocardial extracellular matrix (ECM) properties as internal scaffold 
conformation, mechanics, and composition will modulate cellular differentiation, migration, and adhesion4–8.
In this context, decellularized cardiac tissues provide a close match to the native, physiological microenviron-
ment, as they preserve the inherent stiffness, composition, vasculature network, and three-dimensional frame-
work9, and enable electromechanical coupling with the host myocardium upon implantation10,11. Herein, we 
tested two decellularized scaffolds generated from the myocardium and pericardium, as previously described12,13. 
The scaffolds were either repopulated with porcine adipose tissue mesenchymal stem cells (pATMSCs) or tested 
as cell-free scaffolds. Macro and micromechanics, structural characteristics and protein content of the decellular-
ized scaffolds were evaluated prior to recellularization. The functional benefits associated with both the acellular 
and recellularized scaffolds were assessed in a preclinical MI swine model. Cardiac function was analyzed with 
magnetic resonance imaging (MRI), and accurate infarct size was obtained with late gadolinium enhancement.
Methods
Generation of decellularized myocardial and pericardial scaffolds. Myocardial tissue samples were 
isolated from porcine hearts (n = 22), and surgical samples of pericardial tissue were acquired from 90 patients (63 
males, 27 females; mean age 69 ± 10 years; range 42 to 85 years) undergoing cardiac interventions at our institution, 
with apparently healthy pericardia and after signed consent. This study was revised and approved by the Germans 
Trias i Pujol University Hospital ethics committee, and all the protocols conformed to the principles outlined in the 
Declaration of Helsinki. Both cardiac tissues were decellularized, lyophilized, and sterilized as described elsewhere12,13.
Recellularization of sterilized cardiac scaffolds. The sterilized acellular cardiac scaffolds were repop-
ulated with pATMSCs obtained from porcine pericardial adipose tissue, as previously reported13, to generate 
both the engineered myocardial and pericardial grafts. Initially, the decellularized scaffolds were rehydrated 
with a mixture of 175 μL of peptide hydrogel RAD16-I (Corning, Corning, NY) and 175 μL of GFP+-pATMSCs 
(1.75 × 106) in 10% sucrose (Sigma-Aldrich, St Louis, MO), added dropwise on top of the scaffold. To promote 
hydrogel jellification, α-minimum essential medium eagle (α-MEM) (Sigma-Aldrich) was added over the scaf-
fold. The produced cell-enriched grafts were maintained over one week under standard culture conditions (37 °C, 
95% air, 5% CO2), changing medium every 2 days.
Flow cytometry. Changes in cell viability were assessed by flow cytometry using the Annexin V Apoptosis 
Detection Kit and the 7-amino-actinomycin D (7-AAD) viability staining solution (eBiosciences). Cells 
(2–5 × 105) were labelled according to the supplier’s instructions. The percentage of viable cells was measured by 
using a Coulter EPICS XL flow cytometer with the Expo32 software (Beckman Coulter).
Measurement of micromechanical properties with atomic force microscopy (AFM). Micromechanical 
properties of native myocardial tissue and decellularized and recellularized scaffolds were studied in 5 porcine 
hearts. 50 µm thick slices of fresh myocardium were obtained using a vibratome (0.01 mm/s blade velocity; 2 mm 
amplitude; VT 1200 S, LEICA, Germany) and attached to glutaraldehyde pre-treated glass slides and directly 
measured with atomic force microscopy (AFM). The decellularized and recellularized myocardial scaffolds 
(15 × 5 × 5 mm) were embedded in 3:1 (v:v) solution of optimal cutting temperature medium (OCT, TissueTek, 
USA) in phosphate buffered saline (PBS) 1x and frozen at −80 °C. For AFM measurements, 50 µm thick scaffold 
slices were cut using a cryostat (HM 560 CryoStar, Thermo Fisher, Madrid, Spain), placed on top of positively 
charged glass slides and stored at −20 °C until AFM measurements. To assess the effect of the different steps of 
the recellularization process in tissue stiffness, AFM measurements were performed in myocardial samples after 
lyophilization, sterilization and peptide hydrogel embedding (5 additional porcine hearts). A similar AFM meas-
urement protocol was performed to measure the stiffness of human pericardial samples but in this case native 
pericardial stiffness was measured in 5 × 5 × 2 mm samples adhered with cyanoacrylate to a petri dish.
Before AFM measurements, the slices with OCT were rinsed several times with PBS until OCT was completely 
removed. Then, the slides were placed on the sample holder of a custom-built AFM system12 attached to an inverted 
optical microscope (TE 2000, Nikon, Japan), and force-indentation (F − δ) curves were measured at RT using canti-
levers with a polystyrene microsphere 4.5 μm in diameter attached at its end (nominal spring constant of 0.03 N/m, 
Novascan, Ames, IA). The actual spring constant of the cantilevers was calibrated with the thermal noise method. 












where R is the radius of the microsphere and ν the Poisson’s ratio (assumed to be 0.5).
For each slice, measurements were performed in two locations separated by ~500 µm. At each location, five 
measurements were taken separated by ~10 µm following a linear pattern. At each measurement point, five F − δ 
force curves with a maximum indentation of 1 µm were recorded. Myocardium and pericardium micromechanical 
stiffness was characterized as the average Em computed from the different force curves recorded in each sample.
Measurement of macromechanical properties with tensile testing. For macromechanical meas-
urements, strips (~8 × 1 × 1 mm) of native, decellularized, recellularized, lyophilized, sterilized and hydrogel 
embedded myocardium and pericardium cut along the long-axis with a scalpel were used (n = 5 each). The strips 
were maintained at RT in Krebs-Henseleit solution (Sigma-Aldrich). For tensile testing, each strip was gently 
dried with tissue paper and its mass (M) measured. The unstretched length (L0) of the strip was measured and its 
cross-sectional area (A) computed as
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where ρ is the tissue density (assumed to be 1 g/cm3). One end of the strip was glued with cyanoacrylate to a hook 
attached to the lever of a servocontrolled displacement actuator, which simultaneously stretched the strip and 
measured the stretched length (L) and the applied force (F) (300C-LR, Aurora Scientific, Ontario, Canada). The 
other end of the strip was glued to a fixed hook. Measurements were performed inside a bath with Krebs-Henseleit 
solution at 37 °C. The stress (σ) applied to the strip was defined as:
σ = F
A (3)
Tissue stretch (λ) was defined as:
λ = L
L (4)0
Strips were initially preconditioned by applying 10 cycles of cyclic stretching at a frequency of 0.2 Hz and max-
imum stretch of ∼50%. L0 was measured again and F − L data from 10 more cycles were recorded. The stiffness of 





Stress-stretch (σ − λ) curves were analyzed with Fung’s model, which assumes that EM increases linearly with 
stress as:
α σ β= ⋅ +E ( ) (6)M
where α·β is the value of EM at L0 and α characterizes the strain-hardening behavior of the tissue. Eq. 6 leads to a 
stress-stretch exponential dependence
σ α β β= + −α λ λ−e( ) (7)r
( )r
Figure 1. Internal structure and protein composition of the cardiac scaffolds. Ultrastructure determined by 
SEM of the (A) native myocardium and (B) acellular myocardial scaffolds; or (G) native pericardium and (H) 
acellular pericardial scaffolds. (D,E) Representative images for the native myocardium and decellularized 
myocardial scaffolds, respectively; and (J,K) native pericardium and decellularized pericardial scaffolds showing 
immunostaining for col-I (green), col-III (red), and cTnI (white). (C) SEM images for recellularized myocardial 
and (I) pericardial scaffolds. (F,L) Photographs displaying immunostaining for col-I (green) for recellularized 
myocardial and pericardial scaffolds. Nuclei were counterstained with DAPI (blue). Scale bars = 50 μm.
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where σr and λr define an arbitrary point of the σ − λ curve. The parameters of Eq. 7 were computed for each 
curve by non-linear least-squares fitting using custom built code (MATLAB, The MathWorks, Natick, MA). Using 
these parameters, EM was computed at unstretched length (λ = 1) and at 20% stretch (λ = 1.2). Macromechanical 
stiffness of each heart strip was characterized as the average EM computed from the last σ − λ curves recorded.
Proteomic analysis. The proteins from decellularized tissues were initially extracted and digested as 
detailed in the Supplementary methods. Peptides were analyzed in an Impact II Q-TOF mass spectrometer 
(Bruker, Billerica, MA) using the nano-LC dedicated CaptiveSpray source, coupled to a nanoRSLC ultimate 3000 
system (Thermo Fisher). The peptide separation details are also found in the Supplementary methods.
The mass spectrometer was operated in the Instant Expertise mode, consisting of a cycle of: (i) One MS spec-
trum in 250 msec, mass range 150–2200 Da; (ii) as many as possible MS/MS spectra in 1.75 sec, at 32–250 msec, 
depending on precursor intensity, mass range 150–2200 Da; and (iii) precursor exclusion after one selection. 
Searches against the Swissprot (2015–08) library of mammal protein sequences were performed using the Mascot 
2.5 search engine (MatrixScience, Boston, MA), with a 7 ppm tolerance at the MS level and 0.01 Da tolerance at 
MS/MS level, and a false discovery rate fixed to a maximum value of 1%. The variable modifications were carba-
midomethyl, Gln->pyro-Glu, acetyl, oxidation, and deamidation.
Animal experiment design. All animal studies were approved by the Minimally Invasive Surgery Centre 
Jesús Usón Animal Experimentation Unit Ethical Committee (Number: ES 100370001499) and complied with all 
the guidelines concerning the use of animals in research and teaching, as defined by the Guide for the Care and 
Use of Laboratory Animals (NIH Publication No. 80-23, revised 1996). Seventy-four crossbred Landrace × Large 
White juvenile pigs (30.6 ± 5.5 kg) were submitted to a MI and randomly distributed into five groups as follows:
 1. Control MI (n = 17): no scaffold implantation;
 2. Per-MI (n = 17): cell-free pericardial scaffold implantation;
 3. Myo-MI (n = 8): cell-free myocardial scaffold implantation;
 4. Per-ATMSCs (n = 22): pATMSC-enriched pericardial scaffold implantation;
 5. Myo-ATMSCs (n = 10): pATMSC-enriched myocardial scaffold implantation.
Figure 2. Retention of pATMSCs and scaffold penetrance after recellularization. Photographs of the 
decellularized (A) myocardial and (B) pericardial scaffolds 2 h after cell repopulation. Representative 
recellularized (C) myocardial and (D) pericardial scaffolds 2 h-post recellularization showing labeled 
pATMSCs with NIR815 fluorescent dye (green). Scale bars = 1 cm. (E) Quantification of NIR815 fluorescence 
(arbitrary fluorescence units, AU) for both recellularized cardiac scaffolds. (F) Quantification of cells/mm2 
in recellularized myocardial and pericardial scaffolds one week after recellularization. Data are reported 
as mean ± SEM. *P = 0.018 with Student’s t test. (G,H) Immunohistochemistry images for recellularized 
myocardial and pericardial scaffolds at the scaffold surface, (I,J) upper-middle, (K,L) inferior-middle, (M,N) 
and bottom levels, respectively. The ECM was stained with col-I (green) and pATMSCs with F-actin (red). 
Nuclei were counterstained with DAPI (blue). Scale bars = 50 μm. (O) Quantification of cell density for each 
scaffold depth (surface, upper-middle, inferior-middle, and bottom). Data are displayed as the mean ± SEM. 
**P = 0.013; #P = 0.047 using Student’s t test.
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Figure 3. Ultrastructure, macroscopic, and microscopic mechanical characterization. (A) Pore size and (B) 
pore roundness measurements in both myocardial and pericardial scaffolds. *P = 0.002 with Student’s t test. (C) 
Macroscopic stiffness (EM) of myocardium and pericardium strips measured at the unstretched length (D) and 
20% stretch using tensile testing in native tissues and decellularized and recellularized scaffolds. (E) Microscopic 
stiffness (Em) of myocardium and pericardium 50 μm thick slices measured with AFM, for the same tissue 
conditions. Data are presented as the mean ± SEM. **P < 0.001 between native pericardium and native 
myocardium. #P = 0.044 between recellularized pericardium and recellularized myocardium, using Student’s  
t test. ##P = 0.013 and $P = 0.005 between recellularized myocardium vs. native and decellularized myocardium, 
respectively, with ANOVA test with Tukey’s post-hoc correction for multiple comparisons analysis.
Figure 4. Protein content of decellularized cardiac scaffolds. Number of matrisome and other proteins 
identified in (A) the native myocardium (reported by Guyette et al.16) and (B) in the native pericardium 
(collected by Griffiths et al.17). Total protein content, classified as matrisome and other proteins, for (C) the 
decellularized myocardial and (D) decellularized pericardial scaffolds. (E) Venn diagram displaying the unique 
proteins identified in the native or decellularized myocardium, and their common proteins. (F) Venn diagram 
indicating the number of unique and shared proteins between the native and decellularized pericardia. Results 
are represented as the percentage of the total protein number, and in brackets, as the number of proteins for 
each classification.
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After a left lateral thoracotomy, MI was induced by double ligation of the first marginal branch of the cir-
cumflex artery, as previously described14. After 30 min, the scaffolds were attached over the infarcted area with 
0.1–0.2 mL of surgical glue (Glubran®2, Cardiolink, Barcelona, Spain). After recovery, the animals were housed 
for 40 days before sacrifice.
Cardiac Function Assessment. Cardiac MRI was performed at 1.5 T (Intera, Philips, Amsterdam, 
the Netherlands) in all animals using a four-channel phased array surface coil (SENSE Body Coil, Philips). A 
breath-held, ECG-gated cine steady-state precession MRI was acquired (TR/TE 4.1/2.1 ms; flip angle 60°; field 
of view 320 × 320 mm; matrix 160 × 160 pixels, slice thickness 7 mm; bandwidth 1249.7 Hz/pixel). Delayed 
enhancement images were acquired after intravenous gadolinium (Gd-DTPA, 0.2 mL/kg) using a phase-sensitive 
inversion recovery sequence (TR/TE 4.9/1.6 ms; flip angle 15°; inversion time 157 ms; field of view 330 × 330 mm; 
matrix 224 × 200 pixels; slice thickness 10 mm, bandwidth 282.3 Hz/pixel). The left ventricular ejection fraction 
(LVEF), left ventricular end-systolic volume (LVESV), and left ventricular end-diastolic volume (LVEDV) were 
measured at baseline, 48 h after MI, and before sacrifice. Independent blinded investigators carried out the MRI 
data acquisition and analysis.
Morphometric analysis. Sacrifices were performed at 39.3 ± 7.5 days after MI with an intravenous injection 
of potassium chloride solution. Following a lateral thoracotomy, porcine hearts were excised. The left ventricular 
(LV) infarct area was measured in photographed heart sections obtained 1.5 cm distal to the artery ligation, as 
previously described14. Double-blind quantification was performed by two independent investigators using Image 
J software (version 1.48, National Institutes of Health, Bethesda, MD).
Histopathological and immunohistological analysis. Paraffin slices (4-μm) were stained with hema-
toxylin/eosin (H/E), Movat’s pentachrome, Movat’s modified (for simultaneous collagen and mucopolysaccharide 
acid staining15, and Gallego’s modified trichrome to analyze histological changes and scaffold recellularization 
using a computer-associated Olympus CKX41 microscope (Olympus, Tokyo, Japan) with a ProgRes® CF Cool 
camera (Jenoptik, Jena, Germany).
Frozen 10-μm sections were immunostained with biotinylated Griffonia simplicifolia lectin I B4 (IsoB4; 
1:25; Vector Labs, Burlingame, CA), phalloidin-Atto 565 (1:50; Sigma-Aldrich), smooth muscle actin (SMA; 
1:50; Sigma-Aldrich), type-I collagen (col-I) and type-III collagen (col-III) (1:100; Abcam, Cambridge, UK), 
cardiac troponin I (cTnI) (1:100; Abcam), cardiac troponin T (cTnT) (1:100; AbD Serotec), and elastin (1:100; 
Abcam) primary antibodies to characterize the scaffolds before and after their implantation. Secondary anti-
bodies included Alexa Fluor 488-conjugated streptavidin (1:500; Molecular Probes, Eugene, OR), Cy2, Cy3, 
and Cy5 (1:500; Jackson ImmunoResearch Laboratories, West Grove, PA). All sections were counterstained 
with 4′,6-diamidino-2-phenylindole (DAPI) (0.1 µg/mL; Sigma-Aldrich) and analyzed by confocal microscopy 
(Axio-Observer Z1, Zeiss, Oberkochen, Germany).
Scanning electron microscopy (SEM). Native tissues and decellularized, recellularized scaffolds, and 
engineered grafts after implantation were first washed with sterile distilled water and fixed in 10% formalin 
(Sigma-Aldrich) O/N at 4 °C. Then, samples were washed with sterile distilled water, subsequently dehydrated 
in increasing concentrations of ethanol solutions, and preserved in absolute ethanol at 4 °C, until transference 
Figure 5. Comparison of matrisome proteins in decellularized myocardial and pericardial scaffolds. 
(A) Individual and common proteins of the decellularized myocardial and pericardial scaffolds. Data are 
represented as a relative percentage of the total number of proteins and, within brackets, the number of 
proteins for each classification. The UniProt accession name for the detected proteins is provided for each case. 
(B) Number of proteins for the decellularized myocardial and pericardial scaffolds in each of the following 
matrisome protein subdivisions: collagens, ECM glycoproteins, ECM regulators, ECM-affiliated proteins, 
proteoglycans, and secreted factors.
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to a CO2 critical point dryer (EmiTech K850; Quorum Technologies, Lewes, UK). Finally, the scaffolds were 
sputter-coated with gold using an ion sputter (JFC 1100, JEOL, Tokyo, Japan) and examined with a JSM-6510 
(JEOL) scanning electron microscope at 15 kV.
Pore size measurements. The pore size of both decellularized myocardial and pericardial scaffolds (n = 3 
of each) was blindly evaluated using 10 randomly selected SEM images with a magnification range from 500 to 
1500, and at least 10 different pores from each image were randomly chosen and measured to generate an average 
value. For each pore, the long and short axis lengths were determined using ImageJ software, and pore roundness 
was calculated as the ratio between the short and long axis.
Statistical analysis. Data are represented as the mean ± SEM. Statistical analyses were performed through 
the independent Student’s t test for cell number and density, pore analysis, and myocardium vs. pericardium 
mechanical analysis; paired sample t-test was used to analyze cell viability experiments and one-way analysis of 
variance (ANOVA) with the Tukey’s post-hoc correction for multiple comparisons was conducted for mechanical, 
MRI and infarct size data. SPSS 21.0.0.0 (SPSS, Inc, Chicago, IL) and SigmaPlot 13 (Systat Software Inc, San Jose, 
CA) were used for data analysis. Values were considered significant when P < 0.05 and tendency when P < 0.10.
The datasets generated and/or analysed during the current study are available from the corresponding author 
on reasonable request.
Results
Structural and mechanical characterization. Decellularized scaffolds maintained intrinsic organization 
and spatial three-dimensional distribution of the native matrix fibrils (Fig. 1A,B,G,H). Moreover, two represent-
ative matrix proteins, type-I and type-III collagens, were also properly marked, indicating preservation of matrix 
protein components (Fig. 1D,E,J,K). Of note, analysis of both Annexin V expression and 7-AAD staining by flow 
cytometry showed no significant variations in cell viability between post-thawing and following solubilization 
in 10% sucrose prior repopulation of scaffolds (79 ± 6% vs 75 ± 2%, respectively; P = 0.319) (data not shown). 
Upon scaffold recellularization, the presence of cells was detected using both SEM (Fig. 1C,I) and immunohis-
tochemistry (Fig. 1F,L), confirming cell retention inside the scaffolds one week after repopulation. Two-hours 
post-recellularization, visual examination of the scaffolds suggested a more regular retention of the cell-hydrogel 
mixture for the pericardial scaffold, with no liquid leakage observed (Fig. 2A,B). However, cell quantification did 
not reveal significant differences between the scaffolds (Fig. 2C–E).
Accession Protein Score Category
ANXA2 Annexin A2 59 ECM-affiliated Proteins
CO1A1 Collagen alpha-1(I) chain 89.6 Collagens
CO1A2 Collagen alpha-2(I) chain 46.6 Collagens
CO3A1 Collagen alpha-1(III) chain 89.3 Collagens
CO4A2 Collagen alpha-2(IV) chain 74.8 Collagens
CO5A2 Collagen alpha-2(V) chain 49.7 Collagens
CO6A1 Collagen alpha-1(VI) chain 471 Collagens
CO6A2 Collagen alpha-2(VI) chain 401.7 Collagens
CO6A3 Collagen alpha-3(VI) chain 765.2 Collagens
COCA1 Collagen alpha-1(XII) chain 41.6 Collagens
COEA1 Collagen alpha-1(XIV) chain 149.1 Collagens
CSPG2 Versican core protein 62.5 Proteoglycans
DERM Dermatopontin 72.5 ECM Glycoproteins
EMIL1 EMILIN-1 159.7 ECM Glycoproteins
FBN1 Fibrillin-1 1734 ECM Glycoproteins
FIBA Fibrinogen alpha chain 42.1 ECM Glycoproteins
FIBB Fibrinogen beta chain 75.1 ECM Glycoproteins
FINC Fibronectin 485.2 ECM Glycoproteins
HORN Hornerin 58.4 Secreted Factors
LAMB2 Laminin subunit beta-2 307.8 ECM Glycoproteins
LAMC1 Laminin subunit gamma-1 674.8 ECM Glycoproteins
LUM Lumican 146.2 Proteoglycans
MFAP5 Microfibrillar-associated protein 5 69.2 ECM Glycoproteins
NID1 Nidogen-1 107.4 ECM Glycoproteins
PGBM Basement membrane-specific heparan sulfate proteoglycan core protein 696.8 Proteoglycans
POSTN Periostin 68.5 ECM Glycoproteins
Table 1. Common proteins shared by decellularized myocardial and pericardial scaffolds. List of the common 
proteins (26) found in both decellularized cardiac tissues, with their UniProt accession name, protein name, 
identification score, and matrisome category classification indicated.
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One week post-recellularization, cell retention was significantly higher for pericardial scaffolds (226 ± 14 vs. 
360 ± 41 cells/mm2; P = 0.018) (Fig. 2F). Cell distribution, penetrance, and retention through the scaffold thick-
ness differed between the scaffolds, with a superficial cellular distribution and limited cell migration in myocar-
dial matrix and a uniform distribution with complete migration of pATMSCs throughout the complete scaffold 
thickness in pericardial matrix (Fig. 2G–N) (Surface: 113 ± 21 vs. 52 ± 16 cells/mm2; P = 0.082; upper-middle: 
77 ± 28 vs. 126 ± 52 cells/mm2; P = 0.449; inferior-middle: 22 ± 5 vs. 159 ± 32 cells/mm2; P = 0.013; bottom: 
28 ± 10 vs. 134 ± 36 cells/mm2; P = 0.047, for recellularized myocardial and pericardial scaffolds, respectively) 
(Fig. 2O). The pore size of decellularized scaffolds was significantly higher in pericardial scaffolds (10.2 ± 0.5 vs. 
22.2 ± 1.5 μm; P = 0.002; Fig. 3A), although, no difference in pore roundness was observed between decellular-
ized myocardial and pericardial scaffolds (Fig. 3B).
The mechanical properties of cardiac tissue were evaluated at two different scales: macromechanics by tensile 
testing and micromechanics using AFM. Macroscopic stiffness of the native myocardium was 2.5 ± 0.5 kPa at 
unstretched length and increased to 14.0 ± 2.3 kPa at 20% stretch (Fig. 3C,D). No significant differences were 
found after decellularization and recellularization. The non-linear parameter α (Equation 6) was 13.1 ± 0.7 in 
the native myocardial tissue with no significant changes in the decellularized and recellularized scaffolds. Tensile 
tests did not reveal significant differences between native, decellularized, and recellularized samples neither at 
unstretched length (Fig. 3C) nor at 20% stretch (Fig. 3D). Interestingly, macroscopic stiffness did not change sig-
nificantly when the acellular myocardial scaffold was lyophilized, sterilized, or embedded in RAD16-I hydrogel 
(Supplementary Figure S1A,B). Microscopic stiffness measured in the native myocardium with AFM (13.4 ± 0.9 
kPa) was ∼5-fold higher than macroscopic stiffness found in unstretched strips. Similar to the macroscopic 
mechanical behavior, no significant changes were observed between decellularized, lyophilized, sterilized, or 
rehydrated myocardial scaffolds (Supplementary Figure S1C). In contrast to macroscopic measurements, micro-
scopic stiffness of recellularized scaffolds (22.0 ± 2.2 kPa) was ∼2-fold stiffer than native tissue (13.4 ± 0.9 kPa) 
and decellularized scaffolds (11.6 ± 2.4 kPa) (respectively-test P < 0.05) (Fig. 3E).
There were no significant changes in macroscopic and microscopic stiffness between native, decellularized 
and recellularized pericardium (Fig. 3C–E). No significant differences were found in the unstretched length 
between pericardium and myocardium. However, native pericardial tissue and its recellularized scaffolds were 
∼3-fold stiffer than the myocardium (Student t test P < 0.001 and P < 0.05, respectively) (Fig. 3D). Consistently, 
the non-linear parameter α (Equation 6) of the native (36.9 ± 4.5), decellularized (31.2 ± 3.6) and recellularized 
(23 ± 1.8) pericardium was ∼2 fold higher (P < 0.05) than the myocardium, reflecting a stronger strain-hardening 
behavior. In agreement with myocardium mechanical behavior, no significant changes were found when compar-
ing data along the different recellularization steps (Supplementary Figure S1A–C).
Proteomic characterization. Decellularization of both cardiac tissues was associated with enrichment of 
matrisome/ECM-related proteins, with 7.7% and 9.8% of proteins in native myocardium and pericardium, respec-
tively, and 25.2% and 41.1% in decellularized myocardial and pericardial scaffolds, respectively (Fig. 4A–D). 
For decellularized myocardium matrisome proteins, 24 of the 40 proteins were also in the native tissue, and 16 
proteins were detected exclusively within the decellularized myocardium. In the pericardium, matrisome enrich-
ment was more pronounced: only three proteins were common in the decellularized and native pericardia; while 
forty-eight proteins were only detected in the decellularized pericardium and there was just one unique protein 
in the native pericardium (Fig. 4E,F).
Comparative analysis of the generated acellular myocardial and pericardial tissues revealed they shared 40% of 
the matrisome proteins. Among them, the most remarkable proteins were the different collagen subtypes, respon-
sible for maintaining the ECM structure and modulating cell differentiation; the laminin family and heparan 
Accession Protein Score Category
ANXA7 Annexin A7 68.7 ECM-affiliated Proteins
CEL3B Chymotrypsin-like elastase family member 3B 51.7 ECM Regulators
CO4A1 Collagen alpha-1(IV) chain 60.9 Collagens
CO5A1 Collagen alpha-1(V) chain 46.4 Collagens
COFA1 Collagen alpha-1(XV) chain 98.6 Collagens
FBLN5 Fibulin-5 58.1 ECM Glycoproteins
FBN2 Fibrillin-2 170.7 ECM Glycoproteins
LAMA2 Laminin subunit alpha-2 145.3 ECM Glycoproteins
LAMA4 Laminin subunit alpha-4 186 ECM Glycoproteins
LAMB1 Laminin subunit beta-1 86.8 ECM Glycoproteins
NID2 Nidogen-2 98.6 ECM Glycoproteins
SPB3 Serpin B3 40 ECM Regulators
TGM2 Protein-glutamine gamma-glutamyltransferase 2 173.2 ECM Regulators
TINAL Tubulointerstitial nephritis antigen-like 131.1 ECM Glycoproteins
Table 2. Unique proteins identified for the decellularized myocardial scaffolds. List of the unique proteins (14) 
detected for the acellular myocardial scaffolds, with their UniProt accession name, protein name, identification 
score, and matrisome category indicated.
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sulfate, mainly involved in cell adhesion; and fibronectin, which is involved in different cellular processes such as 
adhesion, survival, and differentiation. In addition, the number of unique proteins identified was notably higher 
for the pericardium, with up to 25 distinctive matrisome proteins vs. just 14 in the myocardium (Fig. 5A and 
Tables 1–3). Finally, subdivision of the ECM-proteins showed more proteins within each ECM protein subtype 
for the decellularized pericardium, except for the collagen subclass (Fig. 5B).
Animal Experimentation. Four animals died during MI induction due to ventricular fibrillation and 4 
were excluded from the study after post-operative infections. Thus, 66 animals were included in the experimental 
protocol in the Per-MI (n = 15), Myo-MI (n = 7), Per-ATMSCs (n = 20), Myo-ATMSCs (n = 7), and Control-MI 
(n = 17) groups.
Cardiac Function Assessment. Cardiac function parameters measured for all animal groups (LVEF, 
LVEDV and LVESV) at different time points have been summarized in Supplementary Table S1. The LVEF 
changes between sacrifice and baseline indicated improved function for Per-MI and Per-ATMSCs (P < 0.001). 
Changes in the LVESV showed a trend towards an improvement in the studied groups (Fig. 6A). Similarly, LVEF 
changes between sacrifice and post-MI were also significant: (P = 0.004). In addition, LVESV changes between 
sacrifice and post-MI were significant (P = 0.031) (Fig. 6B). Changes in the absolute values at 40 days for LVEF 
(P = 0.017) and LVESV (P = 0.020) were also significant.
Infarct size. The LV infarct size was statistically different between the Per-MI (n = 13), Myo-MI (n = 7), 
Per-ATMSCs (n = 18), Myo-ATMSCs (n = 7), and Control-MI (n = 10) animals (5.9 ± 0.9 vs. 7.6 ± 2.3 vs. 4.8 ± 0.6 
vs. 2.5 ± 0.6 vs. 7.7 ± 1.2%, respectively; P = 0.021) (Fig. 6C,D).
Immunohistological analysis. Correct adhesion of the implanted graft with subjacent myocardium was 
observed in all animals after sacrifice. After histological analysis, Movat’s modified staining confirmed the colla-
gen composition of the scaffolds (red), the presence of sulfated mucopolysaccharides (violet), red blood cells (yel-
low) as well as lymphocytes and plasma cells (green). Gallego’s modified staining also confirmed the presence of 
collagen in scaffolds (brilliant green), elastic fibers (fuchsine violet) and squamous epithelium (yellow) (Fig. 7A). 
Moreover, scaffolds of all experimental groups showed functional blood vessels connected to host vasculariza-
tion, which was confirmed by the presence of erythrocytes in the lumen, some even with SMA in the medial layer 
(Fig. 7A,B,D), and newly formed nerves within the scaffolds (Fig. 7B).
Accession Protein Score Category
A1AT Alpha-1-antitrypsin 64.3 ECM Regulators
A2MG Alpha-2-macroglobulin 208.8 ECM Regulators
ANT3 Antithrombin-III 46.6 ECM Regulators
ANXA1 Annexin A1 244.4 ECM-affiliated Proteins
ANXA5 Annexin A5 301.9 ECM-affiliated Proteins
ANXA6 Annexin A6 101.1 ECM-affiliated Proteins
ASPN Asporin 48.2 Proteoglycans
BGH3 Transforming growth factor-beta-induced protein ig-h3 233.6 ECM Glycoproteins
CILP1 Cartilage intermediate layer protein 1 49.5 ECM Glycoproteins
CO5A3 Collagen alpha-3(V) chain 49.3 Collagens
F13A Coagulation factor XIII A chain 86.2 ECM Regulators
FIBG Fibrinogen gamma chain 1172.9 ECM Glycoproteins
FILA2 Filaggrin-2 49.8 Secreted Factors
HEMO Hemopexin 54.7 ECM-affiliated Proteins
LEG1 Galectin-1 143.1 ECM-affiliated Proteins
MGP Matrix Gla protein 60.8 ECM Glycoproteins
MIME Mimecan 125.8 Proteoglycans
PGS1 Biglycan 193.4 Proteoglycans
PGS2 Decorin 212.3 Proteoglycans
PRELP Prolargin 151.2 Proteoglycans
PRG4 Proteoglycan 4 83.7 Proteoglycans
SRPX Sushi repeat-containing protein SRPX 72.5 ECM Glycoproteins
TENX Tenascin-X 56.2 ECM Glycoproteins
VTNC Vitronectin 229.2 ECM Glycoproteins
VWF von Willebrand factor 135.5 ECM Glycoproteins
Table 3. Unique proteins detected in the decellularized pericardial scaffolds. The unique proteins (25) identified 
in the decellularized pericardial scaffold, with the UniProt accession name, protein name, identification score, 
and matrisome category indicated.
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Discussion
Cardiac tissue engineering is mainly based on the combination of a biomimetic scaffold with a cell lineage of 
interest. Here, we characterized the structure as well as the macro and micromechanical scaffold properties 
after decellularization and recellularization of two biological scaffolds from myocardial and pericardial tissue. 
Importantly, no adverse events were associated with pericardium isolation from patients, following a safe cardiac 
surgery procedure previously reported by our group13,18,19. We also evaluated their proteome composition and the 
ability of the two engineered grafts (once recellularized with ATMSCs) to restore cardiac function.
When using an acellular framework for the scaffold design, the ECM inherent properties, such as structure, 
mechanics, and protein composition, must be ideally maintained from the beginning. Matrix disruption due to 
decellularization agents must be minimized to recreate the native physiological milieu, as structure preservation 
has been related to cell differentiation, migration, and alignment7,8. Mechanical stiffness modulates cell adhe-
sion, differentiation, proliferation, and migration4,6,20, as well as contractility21. We have performed a multiscale 
study of myocardial and pericardial mechanics. Stiffness measured at the macroscale is important to assess the 
mechanical matching between the ventricular wall and the attached patch. The similar macroscopic stiffness of 
the native tissue and its recellularized scaffold indicates homogeneous deformation of the patch and healthy ven-
tricular wall during heart beating. On the other hand, stiffness measured with AFM characterizes the mechanical 
properties at the microscale, which is the scale at which cells sense their mechanical microenvironment. AFM 
probes micromechanics of the sample under unstretched conditions. Therefore, the ~5-fold higher stiffness we 
found with AFM (Fig. 3E) as compared to that measured at 0% stretch with tensile assays (Fig. 3C) suggests that 
cells sense a local niche substantially stiffer than the stiffness of the whole 3D matrix scaffold. This differential 
stiffness indicates that scaffold macromechanics is determined by the intrinsic micromechanical properties of the 
ECM as well as by the 3D topology of the matrix. Although no significant differences were found in macroscale 
stiffness at 0% stretch between myocardial and pericardial scaffolds (Fig. 3C), the more marked strain-hardening 
behavior exhibited by the pericardium (~2-fold higher α) resulted in a ~2-fold stiffer pericardial scaffold at 20% 
stretch (Fig. 3D). It should be noted that ventricular tissues are subjected to ~20% stretch during heart beating 
Figure 6. Cardiac function and infarct morphometric analysis. Histograms of the differentials between 40 days 
of follow-up and (A) baseline or (B) post-MI among the Per-MI, Per-ATMSCs, Myo-MI, Myo-ATMSCs, and 
Control-MI groups for LVEF and LVESV. *P < 0.05 vs. control-MI; #P < 0.05 vs. Myo-MI. (C) Percentage of 
the LV infarct area measured in all heart sections for all study groups after 40 days of follow-up (*P < 0.05 vs. 
control-MI); and (D) representative heart sections for each study group showing the infarcted area of the LV. 
Statistical analysis was performed using ANOVA test with Tukey’s post-hoc correction for multiple comparisons.
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indicating that the decellularized pericardial tissue provides a stiffer scaffold under physiological conditions. 
According to our results, macro and micromechanics were well-maintained in both cardiac scaffolds following 
decellularization. No significant mechanical changes were observed after subjecting the decellularized scaffolds 
to lyophilization, sterilization and hydrogel embedment. This allows the conservation and storage of the decellu-
larized scaffolds until later use. Of note, the matrix pore size was significantly larger in pericardial scaffolds, which 
correlated with the findings from a cardiomyocyte transverse section reported in a previous study22. Despite the 
addition of ATMSCs significantly increased myocardial micromechanics, the resulting stiffness for both recel-
lularized myocardial and pericardial scaffolds was within the optimal range (10–20 kPa) to drive physiological 
processes such as cardiomyocyte maturation, contraction, and cardiac lineage commitment, as reported in the 
literature23,24. Therefore, seeding ATMSCs on top of the decellularized myocardium did not have a major impact 
on the matrix micromechanics; rather, it resulted in an overall preservation of the scaffold structure and mechan-
ics following the recellularization process.
Regarding protein content, the native matrisome proteins were preserved in both cardiac tissues upon decel-
lularization, which is consistent with prior studies16, and some of the main cardiac ECM components were iden-
tified, including: collagens (type-I, -III, -IV, -V, -VI), laminin, emilin-1, fibronectin, lumican, heparan sulfate 
proteoglycan, nidogen, and periostin. These key proteins act as mediators or effectors of many cellular processes, 
resulting in favored ATMSC adhesion and survival. Indeed, laminins, fibronectin, and type-I and IV collagens 
enhance cellular survival25,26; whereas, fibronectin27, lumican28, and type-IV and -VI collagens29,30 are associated 
with cell attachment through specific interactions with integrin cell receptors. Galectin-1, vitronectin, decorin, 
and tenascin-X are involved in cell adhesion27,31,32 and were also identified in our decellularized pericardial 
scaffolds. This finding, along with the optimal pore diameter suitable for cell infiltration22,33, may explain the 
increased cell retention and penetrance observed in these scaffolds.
According to the 3 R principle (Replacement, Reduction and Refinement), we included previous animal 
experimentation models13,19,34 in this work, performed by the same surgical team under identical conditions for 
comparison. We demonstrated that the implantation of the engineered cardiac grafts led to improvements in 
LVEF and/or LVESV, limited infarct size expansion, and coupling with the underlying myocardium, as indicated 
by the vascularization and innervation of the grafts. The benefits exhibited here by both recellularized scaffolds 
Figure 7. Histological and immunohistochemical analysis after in vivo scaffold implantation. (A) 
Representative images (top to bottom) of H/E, Movat’s pentachrome, Movat’s pentachrome for simultaneous 
collagen and mucopolysaccharide acid staining and Gallego’s modified trichrome. Scale bar = 100 μm. (B) 
Movat’s pentachrome of the scaffolds from the Per-ATMSCs, Myo-ATMSCs, Per-MI, and Myo-MI groups 
displaying the presence of arterial blood vessels (red arrows), veins (blue arrows), and nerve fibers (yellow 
arrows). Scale bar = 50 μm. (C) Representative SEM images of scaffolds from Per-MI and Myo-MI experimental 
groups after sacrifice. (D) Immunohistochemical images of the scaffolds against IsoB4 (green), SMA (red), and 
elastin (white) antibodies confirming the presence of arteriolar blood vessels positive for SMA. Nuclei appear 
counterstained in blue. Scale bars = 50 μm.
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are greater than those reported for direct intracoronary or intramyocardial injection of ATMSCs35, or administra-
tion of an acellular myocardial36 or pericardial scaffold37. The combination of the cardiac scaffolds with ATMSCs 
showed more improvement than the non-recellularized scaffolds, indicating a synergistic effect, as reported previ-
ously38. Scaffolds may be beneficial for triggering MI salvage, by providing a favorable microenvironment for the 
seeded ATMSCs, and for recruiting endogenous stem cells towards the infarct bed39, boosting both vasculariza-
tion and cardiomyogenesis. The contribution of ATMSCs to MI recovery has also been previously described, and 
the most recent evidence points towards paracrine signaling, rather than direct effects of ATMSCs40. Paracrine 
action would be consistent with a low number of retained or seeded cells, as in our study, being able to promote 
effects41, such as vessel formation, protecting resident cardiomyocytes from apoptosis, and mobilizing resident 
stem cells to potentiate vascularization and cardiomyogenesis42. Remarkably, in the present work, both cell-free 
and ATMSC-recellularized cardiac scaffolds, regardless of their origin, were successfully integrated in host cells, 
undergoing neovascularization and neoinnervation. However, further studies on ECM signaling and/or host cell 
recruitment pathways are required to discern which mechanisms are responsible for these processes.
Conclusions
Two engineered cardiac grafts were successfully generated by combining ATMSCs with either myocardial or 
pericardial acellular scaffolds, which preserved structural framework in both cases. Nevertheless, superior pres-
ervation of mechanical intrinsic properties and higher enrichment of major cardiac ECM proteins was observed 
for pericardial scaffolds. Furthermore, in vitro, the recellularized pericardial scaffold showed higher cell retention 
and penetrance, and a bigger pore size compared to recellularized myocardial scaffolds. In the context of a pre-
clinical MI model, the engineered grafts integrated with the underlying myocardium, with signs of neoinnerva-
tion and neovascularization, and improved cardiac function post-MI.
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